[pending] Claritin, 20 Count, UPC: 655708016305
Pending LLM rewrite. Source: FDA_DRUG D-0266-2026.
- Product
- Claritin, 20 Count, UPC: 655708016305
- Category
- Drug
- Distribution
- Distributed nationwide
Category
FDA recalls of prescription and over-the-counter drugs.
FDA drug recalls cover prescription medicines, over-the-counter products, biologic and gene therapies, and active pharmaceutical ingredients (the raw drug substances that manufacturers compound into finished products). Recall classifications follow the same Class I / II / III system as food, and most published recalls are Class II — the product is unlikely to cause permanent harm but doesn't meet specification.
The most common reasons for a drug recall are out-of-specification potency or dissolution (the active ingredient is present in too high or too low a dose), microbial contamination, particulate matter in injectables, mix-ups during packaging where bottles end up with the wrong tablets, and nitrosamine impurities in certain drug classes. Many drug recalls are at the lot level — the manufacturer's whole product line is still safe to use, but specific production lots are pulled.
If a recall affects your medication: don't stop taking it on your own. Call your prescriber or pharmacist before doing anything. Stopping a prescribed drug abruptly can be more dangerous than the issue prompting the recall. Most drug-recall remedies route through the dispensing pharmacy, who'll either swap your supply for an unaffected lot or coordinate a refund with the manufacturer.
Pending LLM rewrite. Source: FDA_DRUG D-0266-2026.
Pending LLM rewrite. Source: FDA_DRUG D-0263-2026.
Pending LLM rewrite. Source: FDA_DRUG D-0260-2026.
Pending LLM rewrite. Source: FDA_DRUG D-0278-2026.
Pending LLM rewrite. Source: FDA_DRUG D-0272-2026.
Pending LLM rewrite. Source: FDA_DRUG D-0262-2026.
Pending LLM rewrite. Source: FDA_DRUG D-0268-2026.
Pending LLM rewrite. Source: FDA_DRUG D-0271-2026.
Pending LLM rewrite. Source: FDA_DRUG D-0269-2026.
Pending LLM rewrite. Source: FDA_DRUG D-0287-2026.
Pending LLM rewrite. Source: FDA_DRUG D-0257-2026.
Pending LLM rewrite. Source: FDA_DRUG D-0265-2026.
Pending LLM rewrite. Source: FDA_DRUG D-0276-2026.
Pending LLM rewrite. Source: FDA_DRUG D-0282-2026.
Pending LLM rewrite. Source: FDA_DRUG D-0285-2026.
Pending LLM rewrite. Source: FDA_DRUG D-0280-2026.
Pending LLM rewrite. Source: FDA_DRUG D-0286-2026.
Pending LLM rewrite. Source: FDA_DRUG D-0274-2026.
Pending LLM rewrite. Source: FDA_DRUG D-0256-2026.
Pending LLM rewrite. Source: FDA_DRUG D-0284-2026.
Pending LLM rewrite. Source: FDA_DRUG D-0259-2026.
Pending LLM rewrite. Source: FDA_DRUG D-0281-2026.
Pending LLM rewrite. Source: FDA_DRUG D-0264-2026.
Pending LLM rewrite. Source: FDA_DRUG D-0283-2026.
Pending LLM rewrite. Source: FDA_DRUG D-0290-2026.
Looking for a different category? Browse all recalls.